The purpose of the OU College of Pharmacy PGY2 Pediatric Residency is to build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in advanced or specialized practice. This PGY2 residency provides residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care that improves medication therapy. Residents who successfully complete this accredited PGY2 Pediatric Pharmacy Residency should possess competencies that qualify them for a clinical pharmacist and/or faculty position and prepare them to be eligible for attainment of Board of Pharmacy Specialties (BPS) Board Certification in Pediatric Pharmacy (BCPPS).
This one-year position provides the resident with the academic rank of Clinical Instructor with the University of Oklahoma College of Pharmacy (OUCOP). Educational responsibilities and training include didactic (lecture) and experiential (rotation) teaching to Pharm.D. students in addition to other activities. The PGY2 Pediatric Pharmacy resident is expected to complete the Advanced Teaching Skills for Residents teaching certificate program, which requires teaching activities in the clinical arena, the classroom, and the laboratory setting. In addition, the resident will be required to complete an original research project for completion of the residency program; they will be expected to present their research at national meetings and will be encouraged to publish their findings.
The OU College of Pharmacy PGY2 Pediatric residents are expected to achieve 80% of these educational outcomes for the residency. The remaining 20% must be assessed at a minimum of satisfactory progress. These include the objectives under the five required competency areas (R1—patient care, R2—advancing practice and improving patient care, R3—leadership and management, R4—teaching/education/dissemination of knowledge, R5—management of medical emergencies) as well as the objectives under two of the elective competency areas (E1—academia and E4—added skills for pediatric pharmacy scholarship).
In addition to this, residents are also expected to document coverage of the required pediatric disease states listed at the end of the ASHP Educational Outcomes, Goals, and Objectives for PGY2 Pediatric Pharmacy residents. By the end of the program, residents are expected to complete 90% of the required disease topics.
The Downtown Campus of OU Medicine Inc, in Oklahoma City is comprised of two hospitals: OU Medical Center and The Children's Hospital at OU Medical Center. The Children's Hospital at OU Medical Center is a 314-bed teaching hospital with a 93-bed Neonatal ICU, a 13-bed Medical ICU, and a 12-bed Cardiovascular (CV) PICU. It is the only comprehensive children's hospital in the state of Oklahoma.
- Orientation (if applicable)—1 month
- General Pediatrics 1—1 month
- General Pediatrics 2 (Required precepting month for APPE students)—1 month
- Pediatric Medical ICU—1 month
- Neonatal ICU—2 months
- Pediatric Hematology/Oncology—1 month
- Pediatric Nephrology—1 month
- Pediatric CV ICU—1 month
- Research—1 month
- Electives—2-3 months*
*Various options exist for electives based on the resident’s interest. Residents may complete additional rotations in similar areas or seek new experiences in areas of interest. These opportunities include Solid Organ Transplant, Pediatric Pain Management, Toxicology/Poison Control, Pediatric Stem Cell Transplant, and Other (depending upon the resident’s interest and preceptor availability).
- Research Longitudinal Rotation (July-June)
- Longitudinal Teaching Rotation (July-June)**
- Longitudinal Ambulatory Care Rotation (1 half-day per week, July-June)
- Contemporary Pediatric Pharmacy Practice and Management (July-June)
**All PGY2 residents are expected to complete the Advanced Teaching Skills for Residents teaching certificate program.
Other Requirements and Opportunities
The resident delivers at a minimum of two lectures to Pharm.D. students throughout the year. Residents also assist with small group facilitation, lab work, and course coordination. Teaching also occurs throughout the year as the resident presents interdisciplinary in-services to the medical and nursing staff and assists with precepting of Pharm.D. students in the experiential portion of their curriculum. The resident assumes primary precepting responsibility for P4 students during the latter part of the residency.
Residents complete a research curriculum which includes the University of Oklahoma Health Sciences Center Institutional Review Board (IRB) certification for conducting human research and specific research training sessions through Resident Rounds. Each resident designs and executes an original research project under the mentorship of their research committee, which consists of the residency program director, an expert in the practice area in which research will be conducted, and an expert in study design, data analysis, and statistical methods. Residents present preliminary research findings during a podium presentation at the Pediatric Pharmacy Advocacy Group Annual Meeting and the Oklahoma Pharmacy Residency Conference. In accordance with ASHP standards, residents prepare a high-quality manuscript based on their research findings.
The resident participates in the peer-review of at least two manuscripts submitted for publication. The resident is also expected to contribute to the literature through preparation and publication of a newsletter article, a case report or review article, and their original research.
The resident develops practice management skills through participation in institutional projects and committee work at The Children’s Hospital at OU Medical Center. In addition, the resident develops their leadership philosophy through readings and discussions with the leadership preceptor and one-on-one meetings with local pharmacy leaders.
Professional Organization Involvement
Resident involvement in local and national professional organizations (as their residency schedule allows) is encouraged. Examples include:
- Oklahoma Society of Health-System Pharmacists (OSHP)
- American Society of Health-System Pharmacists (ASHP)
- American College of Clinical Pharmacy (ACCP)
- American Association of Colleges of Pharmacy (AACP)
- Pediatric Pharmacy Advocacy Group (PPAG)
University of Oklahoma College of Pharmacy Committees
Resident involvement in college committees is also encouraged. Examples include:
- One academic committee to support the College
- OUCOP department meetings
- Other meetings based on resident interests
Residency Program Director
Peter N. Johnson, Pharm.D., BCPS, BCPPS, FPPAG, FCCM.
Associate Professor, Department of Pharmacy: Clinical and Administrative Sciences. Practice area: Pediatric critical care, pediatric pain management, inpatient general pediatrics
Residency Program Preceptors
Jennifer Dannelley, Pharm.D. Pediatric Clinical Pharmacist, University of Oklahoma College of Medicine. Practice area: Cystic fibrosis, pulmonology.
Jami Johnson, Pharm.D., DABAT. Assistant Director, Oklahoma Center for Poison and Drug Information. Practice area: Toxicology/poison control.
Teresa V. Lewis, Pharm.D., BCPS. Assistant Professor, Department of Pharmacy: Clinical and Administrative Sciences. Practice area: Pediatric nephrology, pediatric renal transplant, inpatient general pediatrics.
Jamie Miller, Pharm.D., BCPS, BCPPS, FPPAG. Associate Professor, Department of Pharmacy: Clinical and Administrative Sciences. Practice area: Neonatology, inpatient general pediatrics.
Phu Nguyen, Pharm.D. Clinical Pharmacy Specialist in Solid Organ Transplant, Oklahoma Transplant Center. Practice area: Adult and pediatric liver, kidney, and pancreas transplant.
Leigh Peek, Pharm.D., BCPS, BCPPS. Pediatric Clinical Pharmacist, The Children’s Hospital at OU Medical Center. Practice area: Pediatric stem cell transplant, and hematology/oncology.
Katie Thompson, Pharm.D., BCPS. Clinical Pharmacy Manager, OU Medical System. Practice area: Pharmacy practice management.
Kristie Williams, Pharm.D., CSPI. Senior Specialist in Poison Information, Oklahoma Center for Poison and Drug Information. Practice area: Toxicology/poison control.
Brittany Powers Shaddix, Pharm.D. (2018-2019)
Residency Program Alumni
Amy Nguyen, Pharm.D. (2016-2017), BCPPS. Clinical Pharmacy Specialist, Pediatric Hematology/Oncology and Critical Care, UCSF Medical Center at Mission Bay/UCSF Benioff Children’s Hospital; San Francisco, CA.
Amanda Capino, Pharm.D. (2015-2016). Clinical Assistant Professor, University of Mississippi School of Pharmacy; Jackson, MS.
Katlyn (Katie) Hughes, Pharm.D., BCPPS (2014-2015). Clinical Pharmacy Specialist—Pediatric Medical ICU, Riley Children’s Hospital at Indiana University Health; Indianapolis, IN.
Bethany Ibach, Pharm.D., BCPPS (2013-2014). Assistant Professor, Texas Tech University Health Sciences Center School of Pharmacy; Abilene, TX.
Megan Andrews, Pharm.D. (2012-2013).
Erin (Lammers) Martin, Pharm.D., BCPS, BCPPS (2011-2012), Pediatric Clinical Specialist, Missouri Health Care Women’s and Children’s Hospital; Columbia, MO.
Misty Miller, Pharm.D., BCPS, AAHIVP (2010-2011), Clinical Assistant Professor, University of Oklahoma College of Pharmacy; Oklahoma City, OK.
Emily (Gish) Benefield, Pharm.D., BCPS, BCPPS (2009-2010), Advanced Clinical Pharmacist, Primary Children’s Medical Center; Salt Lake City, UT.
Brooke (Honey) Gildon, Pharm.D., BCPS, BCPPS, AE-C (2008-2009), Associate Professor, Southwestern University College of Pharmacy; Oklahoma City, OK.
Jamie Miller, Pharm.D., BCPS, BCPPS, FPPAG (2007-2008), Associate Professor, University of Oklahoma College of Pharmacy; Oklahoma City, OK.
Teresa V. Lewis, Pharm.D., BCPS (2004-2005), Assistant Professor, University of Oklahoma College of Pharmacy; Oklahoma City, OK.
Tracy Hagemann, Pharm.D., FCCP, FPPAG, Associate Dean, Nashville Campus and Professor, Clinical Pharmacy at the University of Tennessee College of Pharmacy; Nashville, TN.
Kelly Gabeau Martin, Pharm.D., Dallas, TX.
Chad Reynolds, Pharm.D., Vann Healthcare Pharmacy; Glasgow, KY.
Maria Santerio, Pharm.D., Clinical Pharmacist, Central Florida Medical Center; Tampa, FL.
Renee Bellinger, Pharm.D., Associate Professor, University of Incarnate Word; San Antonio, TX.
Bill Maish, Pharm.D.
Cathy Poon, Pharm.D., FPPAG, Associate Provost for Interprofessional Education and Clinical Programs and Professor of Clinical Pharmacy at the University of the Sciences; Philadelphia, PA.
This residency program is accredited by the American Society of Health-System Pharmacists.